...BRCA1, RAD51, and RPA32, creating a state of HR deficiency that sensitizes PDAC cells to poly(ADP-ribose) polymerase (PA...
...BRCA1/2 have a high risk of breast cancer. Although recent research has suggested that genomic instability via BRCA1/2 h...
...BRCA1/2-associated breast cancer. With ongoing research, PARP inhibitors (PARPi) are currently under extensive investiga...
...BRCA1 and RAD18 genes. Combining IGIS with cell survival, DNA fibre, BrdU alkaline comet assays, and pRPA immunostaining...
...BRCA1-associated ataxia telangiectasia mutated activator 1 (BRAT1) gene mutations can result in lethal neonatal rigidity...
...BRCA1/2, TP53), to environmental determinants as well. Prognostic biomarkers now lead precision medicine: PR, ER, and HE...
...BRCA1 and BRCA2 genes are observed in breast, ovarian, and other cancers. This results in defective homologous recombina...
...BRCA1/RAD51C promoter methylation and HRD was assessed in 244 samples without a PV in HRR genes. BRCA1/RAD51C promoter m...
...BRCA1/2, and others may aid in diagnosis, prognostication, and the selection of targeted therapeutic options. By systema...
...BRCA1 methylation, genomic alterations, HRD and outcomes. Constitutional BRCA1 methylation was detected in 20.6% of pati...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269